— Agilent Technologies (NYSE: A) reported its fourth-quarter 2019 adjusted earnings of $0.89 per share versus $0.85 per share expected.
— Revenue grew by 6% to $1.37 billion versus $1.33 billion expected.
— Life Sciences and Applied Markets Group sales rose 4% on continued strength in Environmental & Forensics markets.
— Agilent CrossLab Group grew by 8% on broad growth across major markets and regions, while Diagnostics and Genomics Group saw 5% growth aided by Pathology and Companion Dx and ongoing demand in Pharma for oligo-manufacturing.
— Looking ahead into the first quarter of 2020, the company expects revenue in the range of $1.34-1.355 billion and adjusted earnings of $0.80-0.81 per share. Analysts expect EPS of $0.84 on revenue of $1.38 billion.
— For the full year 2020, the company predicts revenue in the range of $5.50-5.55 billion and adjusted earnings of $3.38-3.43 per share. The consensus estimates EPS of $3.44 on revenue of $5.55 billion.
We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips
Key takeaways from Cintas’ (CTAS) third-quarter 2023 report
Cintas Corporation (NASDAQ: CTAS) has been growing its market share by diversifying into new areas and through acquisitions. The prudent business model, with a focus on recurring revenues, has helped
Here are a few points to keep in mind if you are considering Starbucks Corporation (SBUX)
Shares of Starbucks Corporation (NASDAQ: SBUX) stayed in green on Thursday. The stock has gained 10% over the past 12 months. The company delivered healthy results for its most recent
ANGO Earnings: AngioDynamics reports loss for Q3; revenue up 9%
AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported a wider loss for the third quarter when the medical device maker's revenues increased by 9%. The company also provided guidance for fiscal